32 results about "Indefinite period" patented technology

A system and/or method which offers customer-driven aggregation of data, with the ability to dynamically modify the filing hierarchy and to store, create and organize digital financial information. The system enables customers to establish a hierarchy of file folders, file any payment whether paper or electronic in a folder for future reference, provide secure storage for an indefinite period for any payment, including credit card payments, debit card transactions, imaged checks, electronic bill payments or account statements. As such, customers can create and change at will their file folder hierarchy and file documents with notes. Customers can set a preference for automatic filing based on pre-established criteria such as folders based standard merchant categories or by month. Customers can also ‘file’ payments when they are created or viewed in the transaction history. The systems of the exemplary embodiments provide a search function, enabling retrieval of documents based on a document storage time stamp, date last accessed, date posted, dollar amount, or by file folder, group, or category. Customers can view document access history. Further, the systems offer customers convenience, privacy, security and prevention of document loss from disaster, and protection from document or identity theft.

A multi-bit memory device with a memory cell means for storing input information for an indefinite period of time. The multi-bit memory means stores information in up to Kn memory states (Kn>1). A memory cell programming means and comparator means is also included. The present multi-bit memory device also includes a voltage divider arrangement with pull-up devices in a memory array to provide stable and accurate reference voltages over process, temperature, and voltage variations.

An adsorbent molded article comprising granular absorbant and binder having sustained adsorption over an indefinite period; an adsorbent unit employing said adsorbent molded article; and a housing employing said adsorbent molded article or adsorbent unit.

A solar powered air vehicle that can stay aloft for indefinite periods of time. The vehicle employs photovoltaic solar cells for primary power and high speed counter-rotating flywheels for energy storage and steering of the vehicle. The flywheels are placed in the wing to reduce airfoil drag. A control law provides three-axis stabilized control of the vehicle by controlling propeller pitch to vary the speeds of the flywheels.

The invention comprises a stacked color photodisplay apparatus using a photosensitive cholesteric liquid crystalline material on which an image can be optically addressed, retained without degradation for an indefinite period of time, electrically erased and a new image addressed. This is similar to a photographic film except that the photodisplay film can be used over and over again similar to digital display but without the cost of addressing electronics. Included is a device for enhancing the brightness of the image and electrooptical devices for optically writing digital images on the photodisplay. Each cell in the stack can be selectively addressed with a different optical image such as the red, green and blue components of a color digital image.

A system for preventing thrombosis in an implantable medical device includes an implantable medical device sized for implantation at least partially within a patient's body. The device includes an at least partially electrically conductive portion that is disposed within a patient's body upon implantation, an electrode coupled to the electrically conductive portion of the device; and a power source coupled to the electrode. The power source provides a negative electric charge to the at least partially electrically conductive portion for an indefinite period of time. The device may be configured to resist thrombosis, infection, and/or undesired tissue growth via the charged conductive portion once implanted. Exemplary embodiments of the implantable medical device include a hemodialysis vasculature graft, a dialysis catheter, a coronary artery, and a heart valve.

The present invention relates generally to an integrated system and method for humidity control and vapor-phase decontamination of laboratory equipment with a multi-component vapor, one component of which is water vapor. The laboratory equipment can be a sealable enclosure such as an incubator, isolator, glove box, clean room, fume hood, safety cabinet, or centrifuge. The carrier gas flow is preferably in a multiple-pass, closed-loop recirculating mode. The humidity control and decontamination can be carried out automatically without user intervention for an indefinite period of time once the system has been installed, the required utilities connected and the desired settings including temperature and humidity level programmed.

The integrated humidity control and decontamination system can be retrofitted onto existing laboratory equipment.

This invention comprises a process for finally bridging the divide between stock markets and commodity markets. This is accomplished by linking the price of a stock directly and solely to the spot price of a specific commodity (e.g., gold, oil, soybeans, etc.). This not only permits the buying/selling of much smaller units than the commodity market offers, but eliminates the expiration feature of futures contracts, permitting buyers/sellers to maintain positions for indefinite periods of time. Price linkage can be assured by basing the stock either on an actual reserve of the associated commodity or through other means (e.g., instant price adjustment to reflect real-time quotes of the spot price, etc.) that ensures appropriate price tracking. Shares may be exchanged for either equivalent units of the associated commodity, for the actual dollar value of the shares, for some combination thereof, or for any other suitable and equivalent value.

The present invention features embodiments of alleviating the impact to a system of stack switches, as well as to neighboring nodes communicating with such a system, when a primary master switch to secondary master switch failover occurs. The features of the present invention, generally enables a system of stack switches to retain, for a fixed or indefinite period of time, its stack address even when multiple primary master to secondary master failovers occur. This way recalculation of certain protocols - e.g., spanning trees and link aggregations - and updating of certain tables - e.g., address resolution protocol (ARP) and routing tables - are minimized.

The present invention discloses a method and system for maintaining the position of headstones in a cemetery. Previously, headstones installed at a cemetery may shift over time. As the ground beneath the headstone is subjected to erosion from frost, rain, snow, and wind, the headstone may settle and eventually sink partially into the ground. In some cases the headstones may become loose and fall, possibly getting damaged. The present invention provides a subterranean bridge comprised of concrete that the headstone rests upon. In this way, the headstone is supported by the concrete bridge structure, and is less affected by soil conditions, ground water, and freeze-thaw cycles. Since, by definition, the headstones are to be at the cemetery for an indefinite period of time, it is desirable to have a system to maintain the position of the headstone for the long term. The bridge is comprised of two caissons and a plinth. The plinth straddles the caissons, and the headstone rests on the plinth, which has drainage means to prevent standing water on the plinth.

The invention provides a method for the insertion of protein in storage vehicles and the recovery of the proteins from the vehicles, the method comprising supplying isolated protein; mixing the isolated protein with a fluid so as to form a mixture, the fluid comprising saturated phospholipids, lipopolymers, and a surfactant; cycling the mixture between a first temperature and a second temperature; maintaining the mixture as a solid for an indefinite period of time; diluting the mixture in detergent buffer so as to disrupt the composition of the mixture, and diluting to disrupt the fluid in its low viscosity state for removal of the guest molecules by, for example, dialysis, filtering or chromatography dialyzing/filtering the emulsified solid.

An improved method of raising funds may include offering products or services from third parties for sale to support the dreams, goals or purposes of the individuals involved and may extend for an indefinite period of time, and thus may be referred to as “dreamraising.” The dreamraising platform may find use with youth and charitable organizations, in an embodiment. The dreamraising platform may create relationships between three unique roles: organizations (any organization in need of raising funds); sellers (youths or other individuals affiliated with the organization); and supporters (purchasers who purchase from the sellers). Through the platform the sellers may create an online store, in which, while setting up their pages, sellers may identify their dream (their strongly desired goal or purpose) to be displayed on their online store page. The infrastructure of the platform enables sellers to sell products or services to their community of supporters. In addition to a customized fundraising page, the seller receives access to automated marketing provided by the dreamraising platform through the use of a sidekick communication platform. The dreamraising fundraising platform, along with the sidekick communication platform, provides the seller with sophisticated digital marketing to increase sales and the ability to track funds raised.

The present invention generally relates to methods of suppressing estrus in breeding or competitive animals comprising parenterally administering to breeding animals an estrus suppressing amount of 17-α-Allyl-17-β-hydroxyoestra-4,9,11-trien-3-one. According to the method of the present invention, estrus can be suppressed for any of a variety of periods including 30 days or more. Furthermore, the method of the present invention includes repeated sustained release doses for an indefinite period.

Receptacle for containing two different products separately and for mixing thereof, which allows the two products to be kept separate for an indefinite period of time without the risk of their being able to mix with one another or to come into contact with one another, and which mixes said products inside the same receptacle when required for use. The receptacle is of the type that has: a container for a first product, provided with a threaded neck and filling opening; a capsule containing a second product, which is open at the upper end thereof, closed at the lower end thereof by means of a frangible skirt, and which is coupled tightly onto the container from the opening of the latter; a cap for closing the container, which includes a wall with thread and tamper-evident ring; and a coaxial internal skirt that ends in a cutting edge for the bottom of the capsule.

This invention is directed to an efficient cryopreservation package design of harvested mammalian tissues and living cultured tissue equivalents made by in vitro technology. The invention involves immersing a mammalian tissue or cultured tissue equivalent in a cryoprotectant solution, agitating the cryoprotectant solution and the immersed tissue to achieve effective penetration of the cryoprotectant solution into the tissue, and then freezing the tissue at a very slow freezing rate. In the freezing step, extracellular ice formation is initiated by seeding. The cryopreserved tissue may be stored for indefinite periods of time prior to use. The cultured tissue equivalent is an in vitro model of the equivalent human tissue, such as skin or cornea, which, when retrieved from storage can be used for transplantation or implantation in vivo or for screening compounds in vitro.

The invention discloses a queuing machine system and a queuing method. The system comprises a priority configuration module, which is used for figuring out queuing time of each number ticket according to number marking information input by a human-machine interaction module as well as a preset priority strategy and is used for generating a time axis on which each number ticket is arranged in sequence according to the queuing time. The method comprises number calling preparation, priority configuration and number calling, wherein the priority configuration comprises the following steps of: the priority configuration module is used for figuring out the queuing time of each number ticket according to the number marking information and the priority strategy and used for generating the time axis; and after receiving calling triggering of a number caller, a queuing machine system management module is used for taking out a number ticket with the most front queuing time from the time axis as a number ticket to be called and used for transmitting a number calling instruction to a number calling device. The queuing machine system using the queuing method provided by the technical scheme of the invention can be used for comprehensively considering various different priority situations without clients to wait for an indefinite period; therefore, the queuing machine system disclosed by the invention is more scientific and reasonable.

The invention refers to the production of antibodies named F5 in a cancer carrier and the effect they exert on the development of guest's tumor. F5 may down regulate the proliferation and life of cancer cells regardless the histological nature of the malignancy and the stage of tumor growth. The novel antibody may be raised exclusively in a tumor-carrier guest by challenge with the immunoglobin antigen FIV Abs. This kind of immunization imitates at a certain extent the scheme of classical vaccination with an extern pathogen justifying thus by a semantic derogation the anti-cancer therapeutic vaccination name. The uniqueness of F5 is the result of the adjustment between the conventional antigen FIV to the reactivity in cancer known as premunition. Theoretical considerations and experimental data bring evidence of the efficiency of multi clonal F5 Abs in the treatment of primary or metastatic tumors. The anticancer effect of F5 is only possible as a result of the structural mimicry of the agent with the cancer autocrine growth factors. The blocking of cancer receptors with F5 Abs may produce regression of the primary or metastatic tumors, or arrest of cancer proliferation for indefinite periods of time or, according to circumstances to reduce quantitatively the radio-chemo therapy and the extension of surgical intervention in case of necessity.